Clinical Research - Investigational Medicinal Product (IMP) Preparation and Dispensing

Download this policy

Document Purpose

The purpose of this procedure is to ensure that IMP for clinical research is prepared and dispensed in accordance with NSW Health, SCHN, regulatory and Protocol requirements. Adherence to this procedure will ensure that: * IMP is accurately and safely prepared, dispensed (including packaged and labelled) and released to clinical research participants in a timely manner as per the protocol; and * Records are maintained in compliance with the SCHN Procedure - Record Keeping [DRAFT].

Additional Resources